Log in
Enquire now
Omthera Pharmaceuticals

Omthera Pharmaceuticals

A company developing therapies to treat dyslipidemia and cardiovascular disease

OverviewStructured DataIssuesContributors

Contents

omthera.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Biotechnology
Biotechnology
Healthcare
Healthcare
Medical software
Medical software
Cancer
Cancer
Technology
Technology
Biology
Biology
Location
Princeton, New Jersey
Princeton, New Jersey
AngelList URL
angel.co/omthera-ph...maceuticals
Pitchbook URL
pitchbook.com/profiles.../51676-75
CIK Number
1,477,5980
Place of Incorporation
Delaware
Delaware
0
Investors
Sofinnova Partners
Sofinnova Partners
NEA (New Enterprise Associates)
NEA (New Enterprise Associates)
IRS Number
263,797,7380
Total Funding Amount (USD)
40,400,000
Latest Funding Round Date
March 14, 2011
Stock Symbol
OMTH
Exchange
New York Stock Exchange
New York Stock Exchange
Latest Funding Type
Series B
Series B
Patents Assigned (Count)
1
Wellfound ID
omthera-pharmaceuticals
Headquarters
New Jersey
New Jersey

Other attributes

Company Operating Status
Closed
SIC Code
2,8340
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Omthera Pharmaceuticals

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.